Variation in DSM-IV Symptom Severity Depending on Type of Drug and Age: A Facets Analysis Michael L. Dennis, Ph.D. Chestnut Health Systems, Bloomington,

Slides:



Advertisements
Similar presentations
Substance Abuse & Older Adults February 2, 2010 Helene Bergman, LMSW. C- ASWCM Mark Zilberman, LCSW.
Advertisements

The Who Behind Pharmaceutical Misuse and Abuse – What We Know About Pharmaceutical Abusers Linda Simoni-Wastila, PhD Associate Professor University of.
Intervening with Adolescent Substance User: What do we know so far about and where do we go from here Michael Dennis, Ph.D. Chestnut Health Systems, Normal,
Advances in Adolescent Substance Abuse Treatment and Research Michael Dennis, Ph.D. Chestnut Health Systems, Bloomington, IL Part of the continuing education.
Crime, Violence, and Managing Client and Public Safety Michael L. Dennis, Ph.D., Chestnut Health Systems, Bloomington, IL Presentation at NEW DIRECTIONS.
Abuse or Dependence? Assessing the Alcoholic patient in the Clinic. Antoni Gual Alcohol Unit Psychiatry Department Neurosciences Institute.
Substance Related Disorders
Pathways to risk: What can we do? Ian Webster. PATHWAYS TO RISK Sven Silburn 2003.
Why target YouthBuild for screening, brief intervention and treatment - or don’t you have enough to do already? Michael Dennis, Ph.D. Chestnut Health Systems,
Using Data to Inform Practice Michael L. Dennis, Ph.D. Chestnut Health Systems, Normal IL Presentation at SAMHSA/CSAT Satellite Session, “ Implementing.
1 Managing Substance Use Disorders (SUDS) as a Chronic Condition Michael L. Dennis, Ph.D. Chestnut Health Systems 720 W. Chestnut, Bloomington, IL 61701,
Welcome to the Open Sky Webinar! We will start at 6pm- see you soon.
The Main Profiles Of Treatment Planning Needs Among Adolescents Presenting For Substance Abuse Treatment Based On Cluster Analysis Rodney R. Funk, Michael.
1 Intervening in the Recovery Process Michael L. Dennis, Ph.D. Christy K Scott, Ph.D. Chestnut Health Systems, Bloomington &Chicago, IL U.S.A. Presentation.
1 Developing Custom GAIN Reports with ReportToExcel David Smith, B.G.S., Michael Vacca, B.Sc. and Dionna Christian Chestnut Health Systems, Bloomington,
Chestnut Health Systems, Normal, IL
1 Characteristics, Needs, Services and Outcomes of Juvenile Treatment Drug Courts compared to Adolescent Outpatient and Adult Treatment Drug Courts Melissa.
Predictors of Change in HIV Risk Factors for Adolescents Admitted to Substance Abuse Treatment Passetti, L. L., Garner, B. R., Funk, R., Godley, S. H.,
 Approximately 750,000 adolescent girls become pregnant each year (The Alan Guttmacher Institute, 2006). Though the adolescent pregnancy rate had been.
Practical Applications of Measurement to Addiction Research (“Why do we care?”) Michael L. Dennis, Ph.D. Chestnut Health Systems, Bloomington, IL Presentation.
Measurement Challenges in Addiction Treatment Research Michael L. Dennis, Ph.D. Chestnut Health Systems, Bloomington, IL Presentation at the International.
Consistent with earlier research, these data found a high rate of co- occurring Axis-I psychiatric disorders. While there was substantial overall agreement,
Trajectories of criminal behavior among adolescent substance users during treatment and thirty-month follow-up Ya-Fen Chan, Ph.D., Rod Funk, B.S., & Michael.
Trauma Issues with Specific Populations: Adolescents & Transition Age Youth OVERVIEW Michael Dennis, Ph.D. and Megan Catlin, M.S. Chestnut Health Systems,
What’s New in DSM-5 For Clinicians Working with Mandated Populations State Specialty Court Conference DuAne L. Young The Change Companies®
Facts In 2008, an estimated 20.1 million Americans aged 12 or older were current (past-month) illicit drug users. (8.0% of the population) million.
Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition – DSM-5 Substance Use Disorders and American Society of Addiction Medicine (ASAM)
Avoiding Risky Drinking Taking a Moderate Approach, Staying Healthy.
©2010 McGraw-Hill Higher Education. All rights reserved. Chapter 4 Definitions of Substance Abuse, Dependence, and Addiction.
North Carolina TASC Clinical Series Training Module Eight: DSM -IV.
Substance Abuse Treatment Reduces Costs to Society; Eliminating Substance Abuse Treatment Increases Costs Michael Dennis, Ph.D.* Christy K Scott, Ph.D.**
Frequency and type of adverse events associated with treating women with trauma in community substance abuse treatment programs T. KIlleen 1, C. Brown.
Assessment of Substance Use Disorders
1 Validation of DSM-IV Substance Use Disorder by Substance and Age Using Rasch Michael L. Dennis, Ph.D.,* Kendon Conrad** and Rodney Funk* *Chestnut Health.
The Relationships Between Increased Exercise, Treatment and Reduced Substance Use Martin J. Dennis, Heartland Community College, Normal, IL and Michael.
AOD Use and Mental Health Disparities during Pregnancy and Postpartum Victoria H. Coleman, Ph.D. & Michael L. Dennis, Ph.D. Chestnut Health Systems, Bloomington,
Systems of Care Outcomes Michael Dennis, Ph.D. Chestnut Health Systems, Bloomington, IL Presentation at “UT CAN Local Academy 2006 Celebration, Integration.
ON THE MOVE Department of Corrections GEORGIA Presented by: Rachael G. Hopkins, LPC, CPCS, CCAADC, CCDP-D, CCS Substance Abuse Unit Risk Reduction Services.
Chapter 11 Subset of Overview by Mental Health Disorders GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available.
Chapter 3 Addictions: Theory and Treatment. Drug Addiction Behavioral pattern of drug use Overwhelming involvement Securing of its supply Tendency to.
Terms & Definitions Samhsa’s Co-Occurring Center for Excellence COCE.
Adolescents’ Perceptions of Sponsors in 12-Step Groups for Substance Abuse Lora L. Passetti Chestnut Health Systems, Normal, IL Sponsorship plays an important.
Adolescence and Substance Use by Rick Sampson, American Institutes for Research ( ) An Overview.
Chapter 15 Subset of Overview by Program GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available from
Introduction Introduction Alcohol Abuse Characteristics Results and Conclusions Results and Conclusions Analyses comparing primary substance of abuse indicated.
Health Disparities Webinar 2/28/2013 Michael L. Dennis, Chestnut Health Systems. Normal, IL Available from
Introduction Results and Conclusions Categorical group comparisons revealed no differences on demographic or social variables. At admission to treatment,
Chapter 6 Subset of Overview by Gender GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available from
Chapter 13 Subset of Overview by Crime and Violence GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available.
M. Fe Caces, Ph.D. Office of National Drug Control Policy Executive Office of the President September 2004 Gender Differences in Drug Treatment Data in.
Chapter 9 Subset of Overview by Risk of Homelessness GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available.
Chapter 17 Subset of Overview by Type of Treatment GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available.
Largest evaluation of treatment outcomes by the State to date 1,890 adult clients recruited from 40 treatment programs across the state Three levels of.
Randomized Controlled CTN Trial of OROS-MPH + CBT in Adolescents with ADHD and Substance Use Disorders Paula Riggs, M.D., Theresa Winhusen, PhD., Jeff.
CHAPTER 4: Assessment, Diagnosis, and Treatment Planning Substance Abuse and Addiction Treatment: Practical Application of Counseling Theory First Edition.
Terms Related to Substance Abuse
Mental and Emotional Health
WHY A FOCUS ON ADDICTIVE BEHAVIORS?
MENTAL HEALTH December 2017.
mental Health conditions
DSM-IV-TR, APA, 2000 Criteria for Substance Dependence:
Substance Use Disorders
Diagnosis and Recognition of OUD
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Living Drug-Free (3:31) Click here to launch video
Office of Aerospace. Medicine
Johns Hopkins University
To explain addiction symptoms, features, incidence and influences
Bassett-UMass MAT ECHO.
Opiate misuse among our seniors
Presentation transcript:

Variation in DSM-IV Symptom Severity Depending on Type of Drug and Age: A Facets Analysis Michael L. Dennis, Ph.D. Chestnut Health Systems, Bloomington, IL Presentation at the International Conference on Outcome Measurement, September 11, 2008, Bethesda, MD. This presentation supported by National Institute on Drug Abuse (NIDA) grant no R37 DA11323 and Center for Substance Abuse Treatment (CSAT), Substance Abuse and Mental Health Services Administration (SAMHSA) contract The opinions are those of the author and do not reflect official positions of the consortium or government. Available on line at or by contacting Joan Unsicker at 720 West Chestnut, Bloomington, IL 61701, phone: (309) , fax: (309) ,

Objectives are to...  Use Rasch to evaluate the distribution of DSM IV criteria substance use disorders (abuse & dependence)  Use Rasch to inform some of the key question that have been raised about the current approach to categorizing severity and variation by substance and age.

Example: Evaluating the Substance Use Disorders (SUD) Concept  Much of our conceptual basis of addiction comes from Jellnick’s 1960 “disease” model of adult alcoholism  Edwards & Gross (1976) codified this into a set of bio- psycho-social symptoms related to a “dependence” syndrome  In practice, they are typically complemented by a set of separate “abuse” symptoms that represent other key reasons why people enter treatment  DSM 3, 3R, 4, 4TR, ICD 8, 9, & 10, and ASAM’s PPC1 and PPC2 all focus on this syndrome  Note that these symptoms are only correlated about.4 to.6 with “use” (e.g., ASI, SFS) or “problem” scales (e.g., MAST, DAST, CAGE) more commonly used in treatment research

DSM (GAIN) Symptoms of Dependence (3+ Symptoms) Physiological n. Tolerance (you needed more alcohol or drugs to get high or found that the same amount did not get you as high as it used to?) p. Withdrawal (you had withdrawal problems from alcohol or drugs like shaking hands, throwing up, having trouble sitting still or sleeping, or that you used any alcohol or drugs to stop being sick or avoid withdrawal problems?) Non-physiological q.Loss of Control (you used alcohol or drugs in larger amounts, more often or for a longer time than you meant to?) r.Unable to Stop (you were unable to cut down or stop using alcohol or drugs?) s.Time Consuming (you spent a lot of your time either getting alcohol or drugs, using alcohol or drugs, or feeling the effects of alcohol or drugs?) t.Reduced Activities (your use of alcohol or drugs caused you to give up, reduce or have problems at important activities at work, school, home or social events?) u.Continued Use Despite Personal Problems (you kept using alcohol or drugs even after you knew it was causing or adding to medical, psychological or emotional problems you were having?)

DSM (GAIN) Symptoms of Abuse (No dependence and 1+ symptoms) h.Role Failure (you kept using alcohol or drugs even though you knew it was keeping you from meeting your responsibilities at work, school, or home?) j.Hazardous Use (you used alcohol or drugs where it made the situation unsafe or dangerous for you, such as when you were driving a car, using a machine, or where you might have been forced into sex or hurt?) k.Legal problems (your alcohol or drug use caused you to have repeated problems with the law?) m.Continued Use after Legal/Social Problems (you kept using alcohol or drugs even after you knew it could get you into fights or other kinds of legal trouble?)

On-Going Debates About SUD Concept Formal assumption that symptoms of “physiological dependence” (either tolerance or withdrawal) are markers of high severity Debate about whether “abuse” symptoms should be dropped, thought of as early dependence, or thought of as moderate/high severity markers that warrant treatment even in the absence of a full syndrome Debate about whether to treat diagnostic orphans (1-2 symptoms of dependence) as abuse or continue to ignore them Concern about whether the current symptoms (which were based primarily on adult data) are appropriate for use with adolescents Concern about the sensitivity to change

Conrad et al 2007 Data Source and Methods  Data from 2474 Adolescents, 344 Young Adults and 661 Adults interviewed between 1998 and 2005 with the Global Appraisal of Individual Needs (GAIN; Dennis et al 2003)  Participants recruited at intake to Early Intervention, Outpatient, Intensive Outpatient, Short, Moderate & Long term Residential, Corrections Based and Post Residential Outpatient Continuing Care as part of 72 local evaluations around the U.S. and pooled into a common data set  Analysis here focuses on the GAIN Substance Use Disorder Scale (SUDS) with symptoms of dependence and abuse overall and by substance. The rating scale is 3=past month, 2=past 2-12 months, 1=more than a year ago and 0=never.  Analyses done with a combination of Winsteps and Facets

Sample Characteristics Adolescents: <18 (n=2474) Young Adult: (n=344) Adults: 26+ (n=661) Male 74%58%47% Caucasian 48%54%29% African American 18%27%63% Hispanic 12%7%2% Average Age Substance Disorder 85%82%90% Internal Disorder 53%62%67% External Disorder 63%45%37% Crime/Violence 64%51%34% Residential Tx 31%56%74% Current CJ/JJ invol. 69%74%45% Note: all significant, p <.01

The GAIN’s Substance Problem Scale (SPS)  DSM-IV Clinical Diagnosis categories and courser specifiers (Kappa of.5 to.7)  Epidemiological Lifetime, Past Year and/or Past Month Diagnosis categories (Kappa of.5 to.7)  Dimensional Symptom counts for lifetime, past year and/or past month with internal consistencies of.8 to.9 (test retest of.7 to.9)  16 items: - 7 symptoms for dependence (including physiological symptoms), - 4 for abuse, - 2 lower severity items (complaints about use, hiding use, weekly use), and - 2 higher severity items (substance induced health and mental health Sx)

Person-Item Map PERSONS- MAP- ITEMS (15% above) |. | 2. +T. S|.########### |. | ########## | S9PWithdrawl. | 1.######### +S. |. | S9KDespiteLegal.######### | S9JHazardousUse S9UDespiteHlth. | S9TGiveUpActs.######### M| S9RCantStop. | S9NTolerance 0.######### +M. |.######### | S9HRoleFailure S9QLossControl. |.######### |. | S9MTroubleFight. | -1.######## +S. | S9STimeConsumin.######## |. S|. |.######## | | -2. +T. | (18% below) | EACH '#' IS 44 Item Mean Person Mean S9E WeeklyUse S9CHidingUse S9DComplaints Added 3 lower severity items S9FMentHlth S9GPhysHlth Adding items increases item spread from 2.2 to 4.2 logits 1st dimension explains 75% of variance (2nd explains 1.2%) Note that DSM criteria overlap and are in a narrow range

Item Relationships Across Substances (Ranked SUD Sx) Rasch Severity Measure Desp.PH/MH (+0.10) Give up act. (+0.05) Can't stop (+0.05) Time Cons. (-0.21) Loss of Contro (-0.10) Hazardous (-0.03) Despite Legal (+0.10) Role Failure (-0.12) Fights/troub. (0.17) Time Cons Role Failure Fights/troub. Loss of Control Hazardous Tolerance Can't stop Give up act. Desp.PH/MH Despite Legal Withdrawal Tolerance (0.00) Withdrawal (+0.34) Physiological Sx: While Withdrawal is High severity, Tolerance is only Moderate Dependence Sx: Other dependence Symptoms spread over continuum Abuse Sx: Abuse Symptoms are also spread over continuum Average Item Severity (0.00)

Symptom Severity Varied by Drug Easier to endorse hazardous use for ALC/CAN Rasch Severity Measure ALC AMP CAN COC OPI ALC AMP CAN COC OPI Time Cons. Role Failure Fights/troub. Loss of Control Hazardous Tolerance Can't stop Give up act. Desp.PH/MHDespite Legal Withdrawal AVG (0.00) ALC (-0.44) AMP (+0.89) CAN (-0.67) COC (-0.22) OPI (+0.44) Easier to endorse fighting/ trouble for ALC/CAN Easier to endorse time consuming for CAN Easier to endorse moderate Sx for COC/OPI Easier to endorse despite legal problem for ALC/CAN Easier to endorse Withdrawal for AMP/OPI Withdrawal much less likely for CAN

Symptom Severity Varied Even More By Age Rasch Severity Measure < < Time Cons. Role Failure Fights/troub. Loss of Control Hazardous Tolerance Can't stop Give up act. Desp.PH/MH Despite Legal Withdrawal < Age Adults more likely to endorse most symptoms More likely to lead to fights among Adol/YA Hazardous use more likely among Adol/YA Continued use in spite of legal problems more likely among Adol/YA

Comparing Substances Symptoms mostly varied around whether people used/had a problem

Rasch Severity by Past Month Status NoneDiagnostic Orphan in early remission Diagnostic Orphan Lifetime SUD in early remission Lifetime SUD in CE 45+ days Abuse Only Dependence Only Both Abuse and Dependence Rasch Severity Measure Diagnostic Orphans (1-2 dependence symptoms) are lower, but still overlap with other clinical groups

Severity by Past Year Symptom Count Rasch Severity Measure 1. Better Gradation 2. Still a lot of overlap in range

Severity by Number of Past Year SUD Diagnoses Rasch Severity Measure Better Gradation 2. Less overlap in range

Severity by Weighted (past month=2, past year=1) Number of Substance x SUD Symptoms Rasch Severity Measure Better Gradation 2. Much less overlap in range

Average Severity by Age Adolescent (<18)Young Adult (18-25)Adult (26+) 1. Average goes up with age 2. Complete overlap in range 3. Narrowing of distribution on higher severity at older ages

Construct Validity (i.e., does it matter?) FrequencyOf Use Past Week WithdrawalEmotionalProblemsRecovery Environment Social Risk DSM diagnosis \a Symptom Count Continuous \b Weighted Drug x Symptom \c,d \a Categorized as Past year physiology dependence, non-physiological dependence, abuse, other \b Raw past year symptom count (0-11) \c Symptoms weighted by recency (2=past month, 1=2-12 months ago, 0=other) \d Symptoms by drug (alcohol, amphetamine, cannabis, cocaine, opioids) Past year Symptom count did better than DSM Weighted Symptom Rasch \c Rasch does a little Better still Weighted symptom by drug count severity did WORSE

Implications for SUD Concept  “Tolerance” is not a good marker of high severity; withdrawal (and substance induced health problems are)  “Abuse” symptoms are consistent with the overall syndrome and represent moderate severity or “other reasons to treat in the absence of the full blown syndrome”  Diagnostic orphans are lower severity, but relevant  Pattern of symptoms varies by substance and age, but all symptoms are relevant  “Adolescents” experienced the same range of symptoms, though they (and young adults) were particularly more likely to be involved with the law, use in hazardous situations, and to get into fights at lower severity  Symptom Counts appear to be more useful than the current DSM approach to categorizing severity  While weighting by recency & drug delineated severity, it did not improve construct validity